← Back to Clinical Trials
Recruiting NCT06378281

NCT06378281 Testing a New Method to Improve Informed Consent in Prison Research

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06378281
Status Recruiting
Phase —
Sponsor Stéphanie Baggio
Condition ADHD
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-05-01
Primary Completion 2026-09-30

Trial Parameters

Condition ADHD
Sponsor Stéphanie Baggio
Study Type INTERVENTIONAL
Phase N/A
Enrollment 100
Sex MALE
Min Age 18 Years
Max Age 65 Years
Start Date 2024-05-01
Completion 2026-09-30
Interventions
Modified teach-to-goal informed consent

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Understanding of informed consent is often limited in prison, due to unique challenges faced by detained people. This study will test a modified "teach-to-goal" informed consent process compared to standard procedures. Conducted within a larger study on psychiatric outcomes, it aims to enhance ethical practices for vulnerable populations.

Eligibility Criteria

Inclusion Criteria: * inclusion in the parent-RCT * age ≥ 18 years * good command of French * absence of acute psychiatric disorder * providing written informed consent for study participation in the parent-RCT Exclusion Criteria: \- none.

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE ADHD TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology